WallStSmart

Tempus AI, Inc. Class A Common Stock (TEM)vsZhongchao Inc (ZCMD)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Tempus AI, Inc. Class A Common Stock generates 9595% more annual revenue ($1.27B vs $13.12M). ZCMD leads profitability with a -13.0% profit margin vs -19.3%. TEM earns a higher WallStSmart Score of 31/100 (F).

TEM

Avoid

31

out of 100

Grade: F

Growth: 8.0Profit: 2.0Value: 5.0Quality: 5.5
Piotroski: 6/9Altman Z: -2.16

ZCMD

Avoid

29

out of 100

Grade: F

Growth: 2.0Profit: 2.0Value: 5.0Quality: 9.0
Piotroski: 4/9Altman Z: 9.29

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

TEM1 strengths · Avg: 10.0/10
Revenue GrowthGrowth
83.0%10/10

Revenue surging 83.0% year-over-year

ZCMD3 strengths · Avg: 10.0/10
Price/BookValuation
0.3x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
9.2910/10

Safe zone — low bankruptcy risk

Areas to Watch

TEM4 concerns · Avg: 3.0/10
Price/BookValuation
16.9x4/10

Trading at 16.9x book value

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Return on EquityProfitability
-89.5%2/10

ROE of -89.5% — below average capital efficiency

Free Cash FlowQuality
$-51.78M2/10

Negative free cash flow — burning cash

ZCMD4 concerns · Avg: 2.3/10
Market CapQuality
$6.96M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-5.9%2/10

ROE of -5.9% — below average capital efficiency

Revenue GrowthGrowth
-32.9%2/10

Revenue declined 32.9%

EPS GrowthGrowth
-91.0%2/10

Earnings declined 91.0%

Comparative Analysis Report

WallStSmart Research

Bull Case : TEM

The strongest argument for TEM centers on Revenue Growth. Revenue growth of 83.0% demonstrates continued momentum.

Bull Case : ZCMD

The strongest argument for ZCMD centers on Price/Book, Debt/Equity, Altman Z-Score.

Bear Case : TEM

The primary concerns for TEM are Price/Book, EPS Growth, Return on Equity. Debt-to-equity of 2.63 is elevated, increasing financial risk.

Bear Case : ZCMD

The primary concerns for ZCMD are Market Cap, Return on Equity, Revenue Growth.

Key Dynamics to Monitor

TEM profiles as a hypergrowth stock while ZCMD is a turnaround play — different risk/reward profiles.

TEM is growing revenue faster at 83.0% — sustainability is the question.

ZCMD generates stronger free cash flow (2M), providing more financial flexibility.

Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

TEM scores higher overall (31/100 vs 29/100) and 83.0% revenue growth. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Tempus AI, Inc. Class A Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Tempus AI, Inc is a healthcare technology company. The company is headquartered in Chicago, Illinois.

Visit Website →

Zhongchao Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · China

Zhongchao Inc. provides health care information, education and training services in the People's Republic of China. The company is headquartered in Shanghai, the People's Republic of China.

Visit Website →

Want to dig deeper into these stocks?